Sign In
Buy NDAQ
$82.49
-0.120 (-0.145%)
At Close: Jun 23, 2026
Carbon Revolution Announces Receipt of Non-Compliance Letter from Nasdaq
04:15pm, Tuesday, 03'rd Jun 2025
GEELONG, Australia, June 03, 2025 (GLOBE NEWSWIRE) -- Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced techno
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
04:15pm, Tuesday, 03'rd Jun 2025
KUALA LUMPUR, MALAYSIA, June 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company that develops i
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:10pm, Tuesday, 03'rd Jun 2025
BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Tuesday, 03'rd Jun 2025
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on June 2, 2025, the Compensation Committee of the company's Board of Directors granted to s
Presidio Regains Compliance with Nasdaq Minimum Bid Price Requirement
04:05pm, Tuesday, 03'rd Jun 2025
SAN DIEGO, June 03, 2025 (GLOBE NEWSWIRE) -- Presidio Property Trust, Inc. (“Presidio” or the “Company”) (NASDAQ: SQFT; SQFTP; SQFTW), an internally managed, diversified real estate investment
Nasdaq Reports May 2025 Volumes
04:05pm, Tuesday, 03'rd Jun 2025
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for May 2025 on its Investor Relations website. A data sheet showing this information can be found at:
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Tuesday, 03'rd Jun 2025
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the compensation committee of KalVista's board of directors granted five new
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:00am, Tuesday, 03'rd Jun 2025
CHARLESTOWN, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and c
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
08:00am, Tuesday, 03'rd Jun 2025
FRAMINGHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that in connection with the hiring
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Tuesday, 03'rd Jun 2025
RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted s
Semilux Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 20-F
07:30pm, Monday, 02'nd Jun 2025
Taipei, Taiwan, June 02, 2025 (GLOBE NEWSWIRE) -- Semilux International Ltd. (NASDAQ:SELX) (“SELX” or the “Company”) announced that it received a delinquency notification letter on May 27, 202
Dow, S&P 500, and Nasdaq all close higher; Magnificent 7's gains; Zscaler CEO on earnings and growth
05:48pm, Monday, 02'nd Jun 2025
Asking for a Trend, anchor Josh Lipton breaks down the day's market trends for June 2, 2025. Markets shrugged off a flare-up of US-China trade tensions, as all three major indexes closed higher on Mon
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Monday, 02'nd Jun 2025
SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Monday, 02'nd Jun 2025
BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 23,820 restricted stock units (“RSUs”) to six newly-hir
Chime Financial IPO: Digital banking service sets target stock price as Nasdaq listing date nears
04:21pm, Monday, 02'nd Jun 2025
Ding, ding, ding! Chime Financial is finally ready to go public.
